GlobeNewswire by notified

Valerie Diele-Braun nominated to succeed Piet van der Slikke as CEO of IMCD as of January 2024

Share

ROTTERDAM, The Netherlands (15 March 2023) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Valerie Diele-Braun to become Chief Executive Officer of IMCD as of January 2024. Valerie will succeed Piet van der Slikke, who in December 2021 announced his intention to retire as CEO in 2024.

Valerie Diele-Braun is currently CEO of CABB Group GmbH, a leading global fine chemicals player and life science company, manufacturing active ingredients as well as advanced intermediates, and has over 20 years of leadership experience in the speciality chemicals and ingredients industry. She has been a member of IMCD’s Supervisory Board as of 30 June 2020.

Janus Smalbraak, chair of IMCD’s Supervisory Board: “Valerie brings a wealth of experience in our sector, leading with an international view and mindset. She has a track record of driving long-term business growth. While managing commercial as well as financial performance, Valerie has a keen eye for the sustainability requirements in the industry. Her nomination is the outcome of a thorough succession process. With Valerie we have found an excellent candidate to ensure the continuation of IMCD’s strong management, driving the business in the future ahead.”

Piet van der Slikke, CEO: “I’m delighted to welcome Valerie to our Management Board. Thanks to her role in the Supervisory Board, we have been able to work together in the last three years, in which she came across as an inspiring colleague with a catching mix of energy, experience and personality. I am looking forward to a smooth hand-over, supporting her to lead IMCD in its ambition for sustainable growth.”

Responsibilities
Valerie Diele-Braun has led the German headquartered CABB Group as CEO since 2018. CABB is a global contract development and manufacturing (CDMO) company, with sites throughout the world and a global client base. Prior she has been a member of the Executive Board of Swiss based chemicals manufacturer Achroma, responsible for two of the three global divisions of the company. She had senior executive positions with DSM Nutritional Products and Quest International (now part of Givaudan). Valerie holds a science degree from the State University of New York.

AGM
The appointment proposal will be put to the shareholders for their approval at the upcoming Annual General Meeting (AGM) to be held on 26 April 2023. Subject to shareholder approval, Valerie Diele-Braun will step down from the Supervisory Board and join the Management Board as of 1 October 2023. She will assume responsibilities as CEO and take over from Piet van der Slikke as of 1 January 2024.

To ensure a smooth leadership transition, Piet van der Slikke will remain available as advisor after the handover until 1 April 2024.

This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation and was issued on 15 March 2023, 07:00 a.m. CET.

Attached, please find the full press release in pdf format.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

Subsea 7 S.A. notification of major holding19.4.2024 19:12:34 CEST | Press release

Luxembourg –19 April 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 19 April 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: 15 April 2024 On 15 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares held by Barclays was 22,559 representing less than 0.01% of the voting rights in the CompanyOn 15 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) were 14,625,242 representing 4.80% of the voting rights in the CompanyOn 15 April 2024 the total number of voting rights in the Company attached to financial instruments with similar

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 202519.4.2024 18:43:36 CEST | Press release

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Leiden, the Netherlands, 19th April, 2024: Pharming Group N.V. ("Pharming" or the "Company") (Euronext Amsterdam: PHARM) announces the final results of its invitation to Eligible Bondholders (as defined below) of the outstanding €125 million 3.00% senior unsecured convertible bonds due 2025 issued on 21 January 2020 (the “2025 Bonds”; ISIN: XS2105716554) to tender for purchase via a reverse bookbuilding process for cash any and all of their 2025 Bonds (the “Invitation”). Pharming announces the repurchase of €123.1 million of the 2025 Bonds, which represents 98.5% of the outstanding aggregate principal amount of the 2025 Bonds, on the basis of a final repurchase price per 2025 Bond equal to €100,000. In addition, the Company will pay accrued and unpaid interest from, and including, 21st January

Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: openbaarmaking over transparantiekennisgeving19.4.2024 18:00:00 CEST | Press release

Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de openbaarmaking over transparantiekennisgeving. Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the publication of a transparency notification. Attachment NL_transparency notification_20240419

23/2024・Trifork Group AG – Shareholders approve all resolutions at the Annual General Meeting 202419.4.2024 17:34:19 CEST | Press release

Company announcement no. 23 / 2024 Schindellegi, Switzerland – 19 April 2024 Shareholders approve all resolutions at the Annual General Meeting 2024 The shareholders of Trifork Group AG (“Trifork“) today approved all resolutions proposed by the Board of Directors at Trifork’s Annual General Meeting 2024 (the “AGM“) which was held at Grabenstrasse 2, 6430 Baar, Switzerland. Dividend payment The shareholders approved the Board of Directors’ proposal to pay a gross dividend of EUR 0.10 per share (equivalent to CHF 0.10 per share) by making a payout from capital contribution reserves to the shareholders. The total gross dividend paid out amounts to CHFk 1,932, equivalent to DKKk 14,809, as calculated per the exchange rate published by the Swiss Federal Customs Administration as of 19 April 2024. The payout from capital contribution reserves is declared in CHF and paid out in DKK. Composition of the Board of Directors The shareholders re-elected Julie Galbo as Chairperson of the Board of Di

HiddenA line styled icon from Orion Icon Library.Eye